JD Health International Inc. (HKG:6618)
Hong Kong · Delayed Price · Currency is HKD 63.45
+0.40 (0.63%)
Sep 3, 2025, 2:45 PM HKT
JD Health International Market Cap
JD Health International has a market cap or net worth of 201.85 billion as of September 2, 2025. Its market cap has increased by 193.00% in one year.
Market Cap
201.85B
Enterprise Value
151.71B
Revenue
71.34B
Ranking
n/a
PE Ratio
38.86
Stock Price
63.45
Market Cap Chart
Since December 8, 2020, JD Health International's market cap has decreased from 343.98B to 201.85B, a decrease of -41.32%. That is a compound annual growth rate of -10.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 2, 2025 | 201.85B | 124.58% |
| Dec 31, 2024 | 89.88B | -27.91% |
| Dec 29, 2023 | 124.67B | -45.05% |
| Dec 30, 2022 | 226.89B | 15.58% |
| Dec 31, 2021 | 196.31B | -58.90% |
| Dec 31, 2020 | 477.66B | 38.86% |
| Dec 8, 2020 | 343.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 262.49B |
| Hansoh Pharmaceutical Group Company | 220.96B |
| Innovent Biologics | 180.52B |
| Sino Biopharmaceutical | 153.99B |
| WuXi Biologics | 146.46B |
| Akeso | 141.82B |
| CSPC Pharmaceutical Group | 125.64B |
| Sichuan Kelun-Biotech Biopharmaceutical | 111.07B |